Previous 10 | Next 10 |
TransMedics Reports Second Quarter 2022 Financial Results PR Newswire Accelerated Commercial Momentum to Achieve Net Revenue of $20.5 million 2022 Revenue Guidance Range Raised to $67 million to $75 million ANDOVER, Mass. , Aug. 1,...
AFL , AMKR , AMRC , ANET , ATVI , AWR , AXNX , BCC , BRX , BSM , CACC , CAR , CF , CLAR , CRK , CSR , CSWC , CVI , DAC , DVA , DVN , DZSI , EBS , EHC , ENSG , EPR , EQC , EVER ,...
TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference PR Newswire ANDOVER, Mass. , July 26, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transp...
TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022 PR Newswire ANDOVER, Mass. , July 18, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transp...
Trying to find winners in a bear market is no easy task. Even some of the best blue-chip investments are struggling this year. The S&P 500 has crumbled 20% thus far, and it could get worse before it gets better. One place where investors can find some winners is in the healthc...
TransMedics (NASDAQ:TMDX) stock rose ~4% on June 28, which also saw Cowen raising its price target on the medical device maker's shares to $39 from $35, while maintaining an Outperform rating. The SA Quant Rating on TMDX is Hold, which which takes into account factors such...
A stock that runs up 1,000% can really increase your net worth. Suppose you invest in all three of these healthcare companies, and two of them go belly up. But one of them increases 1,000%. Even though your accuracy is horrible (you're wrong about 66% of them), that one winner means tha...
Gainers: Elevation Oncology (ELEV) +20%. Cue Biopharma (CUE) +14%. Evelo Biosciences (EVLO) +13%. GeoVax Labs (GOVX) +13%. Immix Biopharma (IMMX) +9%. Losers: Verrica Pharmaceuticals (VRCA) -58%. PMV Pharmaceuticals (PMVP) -10%. TransMedics (TMDX) ...
TransMedics has started 2022 with great operating momentum. Strong results have resulted in shares recovering after a big selloff early this year. I like the promise of the business and continue to hold a long position, but I am not actively adding here. For further details ...
ArcelorMittal S.A. (NYSE:MT) is scheduled to announce Q1 earnings results on Thursday, May 5th, before market open. The consensus EPS Estimate is $3.41 (+76.7% Y/Y) and the consensus Revenue Estimate is $20.83B (+28.7% Y/Y). Over the last 1 year, MT has beaten EPS estimates 75% of the time an...
News, Short Squeeze, Breakout and More Instantly...
TransMedics Group Inc. Company Name:
TMDX Stock Symbol:
NYSE Market:
TransMedics Group Inc. Website:
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024 PR Newswire ANDOVER, Mass. , July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant...
2024-07-04 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) traded at a new 52-week high today and are currently trading at $139.5. So far today, approximately 249.23k shares have been exchanged, as compared to an average 30-day volume of 655.52k shares. TransMedics Group, Inc., a commercial-stage medic...